May 21-23, 2014 | Boston, MA | World Pharma Congress

 

This conference aims to bring together cancer researchers and clinicians working on development of molecularly targeted cancer therapies, and to initiate a knowledge exchange around preclinical models and their optimization. This meeting brings together the best and latest findings in all major areas of cancer research.

 

 

 

 

It will be the opportunity to meet our new BD Team :

Léa CARRIGNON – BD Manager Europe

Joel SCHAEFER – BD Manager North America.

 

Pascal LEURAUD, COO,  will also be attending this event in oncology.

 

Meet them at the Booth #41 and attend Stefano CAIRO’s presentation

 

Session: Tumor Models for Targeted Therapy

Title: Characterization of Post-Chemotherapy Residual Disease in Triple-Negative Breast Cancer PDX Models

Date and Time: Thurday May 22nd at 9:45